Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
- 27 November 2021
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 84 (2) , e27-e29
Abstract
No abstract availableKeywords
Funding Information
- NIHR Oxford Biomedical Research Centre (IS-BRC-1215-20008)
- Wellcome Trust (204969/Z/16/Z)
- Manchester Biomedical Research Centre
- National Institute for Health Research
This publication has 12 references indexed in Scilit:
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyThe Lancet Respiratory Medicine, 2021
- Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency departmentJournal of Infection, 2021
- Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19Cell Host & Microbe, 2021
- Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case seriesJournal of Infection, 2021
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreBMJ, 2020
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health recordsThe Lancet Infectious Diseases, 2018
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- MTML-msBayes: Approximate Bayesian comparative phylogeographic inference from multiple taxa and multiple loci with rate heterogeneityBMC Bioinformatics, 2011